<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3</volume><submitter>Martinez-Marignac V</submitter><journal>Blood cancer journal</journal><pagination>e146</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3789207</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Pharmacological targeting of eIF4E in primary CLL lymphocytes.</pubmed_title><pmcid>PMC3789207</pmcid><pubmed_authors>Shawi M</pubmed_authors><pubmed_authors>Aloyz R</pubmed_authors><pubmed_authors>Martinez-Marignac V</pubmed_authors><pubmed_authors>Miller W</pubmed_authors><pubmed_authors>Pinedo-Carpio E</pubmed_authors><pubmed_authors>Panasci L</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Pettersson F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pharmacological targeting of eIF4E in primary CLL lymphocytes.</name><description/><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Sep</publication><modification>2025-04-29T11:05:02.342Z</modification><creation>2025-04-06T19:49:49.153Z</creation></dates><accession>S-EPMC3789207</accession><cross_references><pubmed>24036945</pubmed><doi>10.1038/bcj.2013.43</doi></cross_references></HashMap>